Zhang S et al. |
Effect of voriconazole and other azole antifungal agents on CYP3A activity and metabolism of tacrolimus in human liver microsomes. |
2012 |
Xenobiotica |
pmid:22106961
|
Ogawa K et al. |
A new approach to predicting human hepatic clearance of CYP3A4 substrates using monkey pharmacokinetic data. |
2013 |
Xenobiotica |
pmid:23153054
|
Jeong H and Chiou WL |
Role of P-glycoprotein in the hepatic metabolism of tacrolimus. |
2006 |
Xenobiotica |
pmid:16507509
|
Imamura R et al. |
ABO-incompatible kidney transplantation with anti-CD20 monoclonal antibodies, intravenous immunoglobulin and plasmapheresis without splenectomy: a case report. |
2006 |
Xenotransplantation |
pmid:16623807
|
Song Z et al. |
Tacrolimus inhibits discordant islet xenograft rejection: a study in the pig-to-rat model. |
2003 |
Xenotransplantation |
pmid:14617270
|
Balamurugan AN et al. |
Effect of various immunosuppressive monotherapies on survival and histopathology of monkey islet xenografts in rats. |
2007 |
Xenotransplantation |
pmid:17669173
|
Miki T et al. |
Hamster-to-rat bone marrow xenotransplantation and humoral graft vs. host disease. |
2001 |
Xenotransplantation |
pmid:11472629
|
Tachibana A et al. |
Repopulation of the immunosuppressed retrorsine-treated infant rat liver with human hepatocytes. |
2013 Jul-Aug |
Xenotransplantation |
pmid:23683097
|
Li J et al. |
[Regulatory effect of FK506 on the expression of CD152 and PD-1 in the liver allo-recipients]. |
2008 |
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi |
pmid:18177621
|
He QH et al. |
[The role of superantigen SEB-induced immunotolerance in the immune privileged site]. |
2003 |
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi |
pmid:15132898
|
Bai YJ et al. |
[Regulatory function of tacrolimus and CsA on CD4/CD8 T lymphocyte subgroups and costimulators on them in allo-liver recipients]. |
2008 |
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi |
pmid:18845086
|
Pan ZX et al. |
[IL-18 expression in whole blood cell cultures from active lupus nephritis and the inhibitory effects of FK506, cyclosporin A and dexamethasone]. |
2004 |
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi |
pmid:15555450
|
Naito T |
[Optimal immunosuppressive therapy based on pharmacokinetics and pharmacodynamics of antimetabolites in clinical practice]. |
2010 |
Yakugaku Zasshi |
pmid:21139397
|
Nagao K et al. |
[Drug development from natural fermentation products: establishing a manufacturing process which maximizes the potential of microorganisms]. |
2010 |
Yakugaku Zasshi |
pmid:21048405
|
Fukudo M |
[Individualized dosage regimen of immunosuppressive drugs based on pharmacokinetic and pharmacodynamic analysis]. |
2007 |
Yakugaku Zasshi |
pmid:17603267
|
Sood S and Muthuraman A |
Activity of tacrolimus: an immunosuppressant, in pyloric ligation-induced peptic ulcer in the rat. |
2009 |
Yakugaku Zasshi |
pmid:19952532
|
Tanaka H et al. |
[Discovery and development of a novel immunosuppressant, tacrolimus hydrate]. |
1997 |
Yakugaku Zasshi |
pmid:9306728
|
Uchida K et al. |
Pharmacokinetics of orally administered tacrolimus in lupus nephritis patients. |
2010 |
Yakugaku Zasshi |
pmid:20046074
|
Niwa T et al. |
Effect of cyclosporine and tacrolimus on cytochrome p450 activities in human liver microsomes. |
2007 |
Yakugaku Zasshi |
pmid:17202802
|
Tanaka Y et al. |
[Effect of tacrolimus on the pharmacokinetics and glucuronidation of SN-38, an active metabolite of irinotecan]. |
2013 |
Yakugaku Zasshi |
pmid:23328499
|